Company Search:
Advanced Search
Sponsored Links
MediGene AG Company Snapshot
MediGene AG operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares MediGene AG with three other companies in this sector in Germany: 4Sc AG (2015 sales of 3.27 million Euro [US$3.53 million] of which 70% was Drug Discovery & Development), Biofrontera AG (4.14 million Euro [US$4.47 million] of which 100% was Pharmaceuticals), and Wilex Ag (2.28 million Euro [US$2.47 million] ).

Sales Analysis. MediGene AG reported sales of 6.81 million Euro (US$7.35 million) for the year ending December of 2015. This represents a sharp decrease of 50.6% versus 2014, when the company's sales were 13.78 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
MediGene AG
  Stock Performance Chart for MediGene AG
  Stock Data: Recent Stock Performance:
  Current Price (3/24/2017): 11.53
(Figures in Euro)
1 Week -5.8%   13 Weeks -5.5%  
4 Weeks 6.8%   52 Weeks 56.7%  
MediGene AG Key Data:
  Ticker: MDG1 Country: Germany
  Exchanges: DUS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2015 Sales 6,808,000
(Year Ending Jan 2016).
Employees: 73
  Currency: Euro Market Cap: 232,178,307
  Fiscal Yr Ends: December Shares Outstanding: 20,136,887
  Share Type: Namenaktie Closely Held Shares: 1,427,921
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.